Globe Life (GL)

• Market cap: $10B
• 1 day: -0.52%
• 5 days: -0.82%
• 1 month: -0.94%
• 3 months: -2.79%
• 6 months: 9.10%
• Year to date: 6.99%
• 1 year: 41.05%
• 5 years: 80.45%
• 10 years: 112.17%
• Sector: Financials
• Industry: Life Insurance

About: Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

Employees: 3,732

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

104% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 47

9% more capital invested

Capital invested by funds: $7.15B [Q3] → $7.78B (+$629M) [Q4]

8% more funds holding

Funds holding: 519 [Q3] → 561 (+42) [Q4]

7.55% more ownership

Funds ownership: 75.52% [Q3] → 83.08% (+7.55%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 5 [Q3] → 5 (+0) [Q4]

16% less call options, than puts

Call options by funds: $91.3M | Put options by funds: $108M

16% less repeat investments, than reductions

Existing positions increased: 168 | Existing positions reduced: 200

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $117 3% downside
• Avg. target: $137 14% upside
• High target: $147 22% upside

4 analyst ratings

• positive: 3 75%
• neutral: 1 25%
• negative: 0 0%

Wells Fargo Elyse Greenspan 66% 1-year accuracy 74 / 112 met price target	16% upside $139	Overweight Maintained	6 May 2025
Piper Sandler John Barnidge 53% 1-year accuracy 25 / 47 met price target	22% upside $147	Overweight Maintained	2 May 2025
Morgan Stanley Nigel Dally 64% 1-year accuracy 7 / 11 met price target	3% downside $117	Equal-Weight Maintained	10 Apr 2025
JP Morgan Jimmy Bhullar 60% 1-year accuracy 21 / 35 met price target	21% upside $145	Overweight Maintained	2 Apr 2025